Стратегии реперфузии миокарда у пациентов с Сахарным диабетом 2 типа
https://doi.org/10.25694/URMJ.2019.02.24
Аннотация
Реваскуляризация имеет важное значение в лечении пациентов с острым коронарным синдромом в растущей популяции больных с СД 2 типа. Совокупность неблагоприятных патофизиологических и анатомических особенностей атеросклеротического поражения КА у пациентов с СД 2 типа обуславливает худший прогноз и снижает ответ на реваскуляризацию миокарда. Возможность модифицировать эти факторы остается чрезвычайно трудной задачей. Наиболее перспективными подходами является выбор оптимального метода реваскуляризации, а также своевременная диагностика СД 2 типа, определение степени его компенсации, качественная коррекция выявленных нарушений углеводного обмена и определение алгоритмов дальнейшего ведения пациентов.
Список литературы
1. Reboussin DM. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal.2017;1: 56-66.
2. Cassese S, Byrne RA, Ndrepepa G. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet. 2016: 387; 53-54.
3. Gajos G.Diabetes and cardiovascular disease: from new mechanisms to new therapy. Pol Arch Intern Med. 2018; 29: 128-129.
4. Baron T. Myocardial Infarction.Int.J Cardiol.2018; 3:254-256.
5. Zhang JW, Zhou YJ. Association of silent hypoglycemia with cardiac events in non-diabetic subjects with acute myocardial infarction undergoing primary percutaneous coronary interventions. BMC Cardiovasc Disord.2016;26:16-17.
6. Ramanathan K, Abel JG, Park JE, Fung A, Mathew V, Taylor CM, Mancini GBJ, Gao M, Ding L, Verma S, Humphries KH, Farkouh ME. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. J Am Coll Cardiol. 2017; 19: 2995-3006.
7. Nyström T, Sartipy U, Franzén S, Eliasson B, Gudbjörnsdottir S, Miftaraj M, Lagerqvist B, Svensson AM, Holzmann MJ.PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease. J Am Coll Cardiol. 2017; 19: 1441-1451.
8. Kumar A, Wagener JF, Wojdyla D, Jones WS, Patel MR, Rao SV.Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels. J Invasive Cardiol.2018; 30:51-55.
9. Pandey A, McGuire DK, deLemos JA.Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG). Circulation: Cardiovascular Quality and Outcomes.2016;9:197-205
10. Wang R, Mei B, Liao X, Lu X, Yan L, Lin M, Zhong Y, Chen Y, You T. Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Disord. 2017; 12:17-18.
11. Li HR, Hsu CP, Sung SH, Shih CC, Lin SJ, Chan WL, Wu CH, Lu TM. Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Patients with Diabetic Nephropathy and Left Main Coronary Artery Disease. Acta Cardiol Sin. 2017; 33 :119-126.
12. Gajos G. Diabetes and cardiovascular disease: from new mechanisms to new therapies/Gajos G//. Pol Arch Intern Med.- 2018.- 29.-Р. 128
13. Li PI, Wang JN, Guo HR.A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus. // Li PI/[et al] // Diabetes Res Clin Pract.- 2018.- 24.-Р.139
14. American Diabetes Association Standards of Medical Care in Diabetesd /Diabetes Care// 2017.-40.-S1-S2.
15. Khan AA, Chung MJ, Novak E, Brown DL. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial. J Am Heart Assoc. 2017;13:6-7.
16. Birkner K, Hudzik B, Gqsior M.The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction. Torakochirurgia Pol. 2017;14:127-132.
17. De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic. Front Endocrinol (Lausanne). 2018:17:7-9.
18. Al-Humaidi G, Sarikaya I, Elgazzar AH, Owunwanne A. Myocardial perfusion abnormalities in asymptomatic type 2 diabetic patients. J Saudi Heart Assoc. 2018;30:3-8.
19. Moura FA, Cintra R, Carvalho LSF, Santos SN, Modolo R, Munhoz DB, Quinaglia E Silva JC, Coelho OR, Nadruz W, Sposito AC. Adverse outcome has a U-shaped relation with acute phase change in insulin sensitivity after ST-Elevation Myocardial Infarction. Int J Cardiol. 2018;1:22-24.
20. Al-Humaidi G, Sarikaya I, Elgazzar AH, Owunwanne A. Myocardial perfusion abnormalities in asymptomatic type 2 diabetic patients. J Saudi Heart Assoc. 2018;3:4-8.
21. Patel N, Chen O, Donahue C, Wang B, Fang Y, Donnino R, Natarajan S. Impact of diabetes on heart failure incidence in adults with ischemic heart disease. J Diabetes Complications. 2017;31:15-17.
22. Johansson I, Dahlström U, Edner M, Näsman P, Rydén L, Norhammar A. Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure. J Am Coll Cardiol. 2016; 27:1-4.
23. Kähm K, Laxy M, Schneider U, Rogowski WH, Lhachimi SK, Holle R. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes Care. 2018; 18:17-63.
24. Nordenskjöld AM, Baron T, Eggers KM, Jernberg T, Lindahl B. Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease.2017;1:5-6.
25. Kosiborod M. Hyperglycemia in Acute Coronary Syndromes: From Mechanisms to Prognostic Implications. Endocrinol Metab Clin North Am. 2018;47:185-202.
26. De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic. Endocrinol Metab Clin North Am. 2018;47:185-202.
27. Park HW, Kang MG, Kim K. Long-term prognosis and clinical characteristics of patients with newly diagnosed diabetes mellitus detected after first acute myocardial infarction: from KAMIR-NIH Registry. Korean Circ J. 2018;48:134-147.
28. Farhan S, Redfors B, Maehara A, McAndrew T, Ben-Yehuda O, De Bruyne B, Mehran R, Giustino G, Kirtane AJ, Serruys PW, Mintz GS, Stone GW. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study. JACC Cardiovasc Imaging. 2017; 14:19-36.
29. Golikov AP, Berns SA, Stryuk RI, Shmidt EA, Golikova AA, Barbarash OL. Prognostic factors in patients with non-ST-segment elevation acute coronary syndrome concurrent with type 2 diabetes mellitus (according to the results of the registry)].Ter Arkh. 2017; 89:65-71.
30. Bahtiyar G, Gutterman D, Lebovitz H.Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep. 2016; 16:1-16.
31. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K,
32. A.M. Taha, H.O. Mirghani.Basic clinical characteristics and hospital outcomes of acute coronary syndrome patients. Sudan Sudan Journal of Medical Sciences.2017.;12:2 -10.
33. Chia DB, Wong LY, Liu DYK, Toh MPHS. Predictive factors of developing type 2 diabetes mellitus, Acute Myocardial Infarction and stroke in a cohort with Impaired Fasting Glucose in Singapore. Diabetes Res Clin Pract. 2017; 132:59-67.
34. Kosiborod M. Hyperglycemia in Acute Coronary Syndromes: From Mechanisms to Prognostic Implications. Endocrinol Metab Clin North Am. 2018;47:185-202.
35. Kim EJ, Jeong MH, Kim JH, Ahn TH, Seung KB, Oh DJ. Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients. Int J Cardiol. 2017;23:9-15.
36. Kataja A, Tarvasmäki T, Lassus J, Cardoso J, Mebazaa A, K0ber L. The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock-results from the CardShock Study. Int J Cardiol. 2017;226:48-52.
37. Abdin A, Pöss J, Fuernau G, Ouarrak T, Desch S, Eitel I, de Waha S, Zeymer U, Böhm M, Thiele H. Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol.2018;8:78-80.
38. Kalinczuk L, Zielinski K, Pr^gowski J, Przyluski J, Karcz M, Bekta P, Ciszewski M, Dzielinska Z, Witkowski A, Demkow M. Higher admission glycaemia independently of diagnosed or unrecognised diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and higher mortality after primary angioplasty. Kardiol Pol. 2018;76:594-601.
39. Xing Z, Zhang L, Liu Z, He P, Yang Y, Wulasihan M. Prognostic value of glucose metabolism for non-ST-segment elevation infarction patients with diabetes mellitus and single concomitant chronic total occlusion following primary percutaneous coronary intervention. Medicine (Baltimore). 2017; 96:8-36.
40. She J, Deng Y, Wu Y, Xia Y, Li H, Liang X, Shi R, Yuan Z. Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Diabetol.2017;8:9-7.
41. Cheng G, Mahmoudi H, Chokshi B, Fernandez M, Kazemi V, Lamaa N. The relationship between fasting blood glucose variability and coronary artery collateral formation in type 2 diabetes patients with coronary artery disease. Coron Artery Dis. 2017; 28:486-491.
42. Koyfman L, Brofain E, Erblat A, Kovalenko I, Reina YY, Bichovsky Y, Borer A, Friger M, Frenkel A, Klein M. The impact of the blood glucose levels of nondiabetic critically ill patients on their clinical outcome. Anaesthesiol Intensive Ther. 2018;50:20-26.
43. Su Y-W, Hsu C-Y, Guo Y-W, Chen H-S. Usefulness of the plasma glucose concentration-to-HbA1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. DiabetesMetab.-2017;43:7-8.
44. Savonitto S, Morici N, NozzaA, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diab Vasc Dis Res.2018 ;15:14-23.
45. Дедов И.И., Шестакова М.В., Александров А.А., Алгоритмы специализированной медицинской помощи больным сахарным диабетом (9-й выпуск). Под редакцией И.И. Дедова, М.В. Шестаковой. Cахарный диабет. 2018;14: 2-72.
46. Olariu E, Pooley N, Danel A, Miret M, Preiser JC.A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS One. 2018; 6:13-15.
47. Su JB, Yang XH, Zhang XL, Cai HL, Huang HY, Zhao LH, Xu F, Chen T, Cheng XB, Wang XQ, Lu Y. The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes. PLoS One.2017;28:1-2.
48. Ninkovic VM, Ninkovic SM, Miloradovic V, Stanojevic D, Babic M, Giga V, Dobric M, Trenell MI, Lalic N, Seferovic PM, Jakovljevic DG. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016;53: 37-44.
49. Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis.2018;25:1-19.
50. Rezabakhsh A, Montazersaheb S, Nabat E, Hassanpour M, Montaseri A, Malekinejad H, Movassaghpour AA, Rahbarghazi R, Garjani A. Effect of hydroxychloroquine on oxidative/nitrosative status and angiogenesis in endothelial cells under high glucose condition. 2017; 7:219-226.
51. Smolková B, Bonassi S, Buociková V, Dušinská M, Horskd A, Kuba D4, Džupinková Z4, Rašlová K, Gašparoviċ J, Sliž I, Ceppi M, Vohnout B, Wsólová L, Volkovová K.Genetic determinants of quantitative traits associated with cardiovascular disease risk. Mutat Res. -2015;778:18-25.
52. Wsolová L. American Diabetes Association Standards of Medical Care in Diabetes 2017;40:1-93.
53. Hathi V, Anadkat M. A Comparative Study of In-Hospital Outcome of Patients with ST-Segment Elevation Myocardial Infarction with and Without Diabetes Mellitus, after Thrombolytic Therapy; In Government Hospital of Rajkot, Gujarat, India. J Assoc Physicians India.2017;65:22-25.
54. Mashaly A, Rha SW, Choi BG, Baek MJ, Ryu YG, Choi SY, Byun JK, Li H, Shim MS, Jang WY, Kim W, Kang JH, Park EJ, Choi JY, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ. Impact of diabetes mellitus on 5-year clinical outcomes in patients with chronic total occlusion lesions. Coron Artery Dis. 2018; 29: 119-126.
55. Gao HY, Zhang EL, Liu QR, Gu HQ, Zhang H, Zheng Z, Yang YJ, Gao RL, Wu YJ. Impact of diabetes duration on 3-year clinical outcomes following coronary revascularization Coron Artery Dis.2017;28:151-158.
56. Li Y, Dong R, Hua K, Liu TS, Zhou SY, Zhou N, Zhang HJ.
57. Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus. Chin Med J (Engl). 2017; 20:2-15.
58. Gansera B, Delalic A, Eszlari E, Eichinger W.14-Year Results of Bilateral versus Single Internal Thoracic Artery Grafts for Left-Sided Myocardial Revascularization in Young Diabetic Patients. Thorac Cardiovasc Surg. 2017;65: 272-277.
59. Новикова Е.С, Комаров А.Л, Гуськова Е.В. Достаточно ли шкалы SYNTAX для оценки риска больных, подвергаемых плановым чрескожным коронарным вмешательствам. Атеротромбоз.2017; 1:80-93.
60. Baeza-Román A, de Miguel-Balsa E, Latour-Pérez J, Carrillo-López A.Predictive power of the grace score in population with diabetes. Int J Cardiol.2017;248:73-76.
61. Borja Ibanez, Stefan James, Stefan Agewall. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal.2017; 1:66-68.
62. Massimo F. Piepoli, Arno W. Hoes Stefan Agewall 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal.2016.;37: 2315-2381
Рецензия
Для цитирования:
Беляева НГ. Стратегии реперфузии миокарда у пациентов с Сахарным диабетом 2 типа. Уральский медицинский журнал. 2019;(2):35-41. https://doi.org/10.25694/URMJ.2019.02.24
For citation:
Beliaeva NG. Strategies of reperfusion in patients with type 2 diabetes mellitus. Ural Medical Journal. 2019;(2):35-41. (In Russ.) https://doi.org/10.25694/URMJ.2019.02.24
Просмотров:
105
Послать статью по эл. почте 